MYCN and neoplasm: The risk classification (very low risk, low risk, intermediate risk, or high risk) is based primarily on age of the patient (younger or older than 18 months), International Neuroblastoma Staging System (INSS) stage [61], MYCN status, ploidy of tumor cells, and Shimada histology.